New analysis of official records from the National Institute of Health (NIH) have revealed that just 365,000 people took part in a clinical trial for Type 2 Diabetes in 2021, despite 37.3 million people in the US living with the condition – or more than 11% of the population.
Biogen expects to reduce headcount by 1,000 under $700M operational savings plan
Fresh off two FDA green lights — a full approval for Alzheimer’s and an accelerated nod in ALS — Biogen CEO Chris Viehbacher is bringing
July 26, 2023